Hot Deals:
amol minechem 601.00 (0.17 %) anglo french drugs 930.00 (3.33 %) anugraha valve 280.00 (1.82 %) apl metals 40.00 (-2.44 %) apollo fashion 107.00 (1.90 %) archit nuwood 500.00 arkfin investments 50.00 arohan 202.00 (1.00 %) assam carbon 265.00 (1.92 %) avalokiteshvar 242.00 (0.83 %) axles india 610.00 (1.67 %) balmer lawrie 202.00 (1.00 %) bharat hotels 345.00 (1.47 %) bima mandi 235.00 (-2.08 %) bira 555.00 (-0.89 %) boat 1,380.00 (-1.43 %) c & s electric 840.00 (-1.18 %) cable corporation 13.00 (-0.76 %) capgemini 11,900.00 (0.85 %) care health 186.00 (-1.59 %) carrier aircon 545.00 (-0.91 %) cial 326.00 (0.31 %) csk 170.00 (-1.16 %) dalmia refract 260.00 (1.96 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 440.00 (3.53 %) electronica plastic 2,100.00 (-0.99 %) elgi ultra 400.00 elofic 2,100.00 (2.44 %) esl steel 46.00 (1.10 %) fincare business 86.00 (3.61 %) fincare sfbl 205.00 (1.49 %) fino paytech 133.00 (-1.48 %) flipkart india 231,001.00 (0.00 %) frick india 15,600.00 (-0.95 %) gkn driveline 1,325.00 (-0.38 %) godavari bio 71.00 (1.43 %) goodluck defence 235.00 (2.17 %) group pharma 300.00 gynofem healthcare 63.00 (-3.08 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,120.00 (-0.88 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,300.00 (-1.74 %) hella india 910.00 (1.11 %) hero fincorp 1,990.00 (-0.50 %) hexaware 720.00 (-2.70 %) hicks 1,450.00 (2.11 %) hira ferro 180.00 (2.86 %) honeywell electrical 6,200.00 (1.64 %) ikf finance 312.00 (0.65 %) incred financial 10.00 (1.01 %) incred holdings 165.00 (-1.79 %) india carbon 1,135.00 (-1.30 %) india exposition 121.00 (0.83 %) indian potash 3,250.00 (1.56 %) indian seamless 175.00 (2.94 %) indo alusys 25.75 (-0.96 %) indofil 1,030.00 (0.49 %) infinite computer 405.00 (1.25 %) inkel 29.00 (-3.33 %) jana small finance bank 75.00 kel 610.00 (-2.40 %) kial 126.00 (-1.56 %) klm axiva 15.75 (1.61 %) kurlon limited 1,255.00 (0.40 %) lava 49.00 (-2.00 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 3,050.00 (0.66 %) martin & harris 975.00 (-1.52 %) matrix gas 950.00 (-1.04 %) merino 3,350.00 (1.52 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 410.00 (-2.38 %) mobikwik 595.00 (-0.34 %) mohan meakin 2,150.00 (2.38 %) mohfl 13.60 (-0.73 %) msei 1.15 (-0.86 %) msil 36.00 (2.86 %) nayara energy 595.00 (-0.83 %) nayara energy ncd 315.00 (3.28 %) ncdex 220.00 (-0.90 %) ncl buildtek 310.00 (3.33 %) ncl holdings 92.00 (1.10 %) northern arc 400.00 nsdl 825.00 (1.85 %) nse 5,700.00 (1.79 %) orbis financial 340.00 (0.29 %) oswal minerals 60.10 (-1.48 %) otis 3,700.00 (-0.67 %) oyo 43.50 (-1.14 %) panasonic appliances 262.00 (0.77 %) paymate india 520.00 (-0.95 %) pharmeasy 8.50 (-2.30 %) pharmed limited 480.00 (2.13 %) philips domestic 720.00 (-1.37 %) philips india 910.00 (-1.09 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 255.00 (-1.92 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 505.00 (1.00 %) resins plastics 475.00 (3.26 %) ring plus aqua 530.00 (0.95 %) rrl 1,275.00 (2.00 %) rrp s4e innovation 345.00 (-1.43 %) sab miller 490.00 (2.94 %) sbi amc 2,150.00 (0.94 %) sbi general insurance 620.00 (3.33 %) scottish assam 480.00 (2.13 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,330.00 (-0.75 %) smile microfinance 55.00 (1.85 %) sterlite power 748.00 (-0.27 %) studds 915.00 (-1.08 %) svsml 315.00 (2.94 %) swiggy 355.00 (1.43 %) t stanes 810.00 (1.25 %) tata capital 1,040.00 (-0.95 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,300.00 (1.96 %) urban tots 92.00 (2.22 %) utkarsh coreinvest 310.00 (3.33 %) vadilal dairy 10.00 vikram solar 285.00 (-1.72 %) vivriti capital 1,150.00 (-0.86 %) waree energies 2,150.00 (-0.46 %)
×

VLCC Health Care Ltd Annual Report and Financials

VLCC Health Care Limited (VLCC) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
VLCC Health Care Limited

VLCC Health Care Limited Balance Sheet (Rs in Lakhs)

Particulars

 31 March 2021

 31 March 2020

ASSETS

 

 

Non-current assets

 

 

Property, plant and equipment

25,116.00

28,078.00

Capital work-in-progress

482

295

Goodwill

1933

1916

Other intangible assets

257

366

Right-of-use-assets

17472

21398

Loans

874

706

Other financial assets

338

720

Income tax assets (Net)

324

472

Deferred tax assets (Net)

5,264.00

4,917.00

Other non-current assets

88.00

69.00

Current assets

 

 

Inventories

5,719.00

7,352.00

Trade receivables

4,686.00

3,474.00

Loans

980.00

1,218.00

Cash and cash equivalents

3834

1214

Other financial assets

82

149

Other current assets

1785

2789

TOTAL ASSETS

69,234.00

75,133.00

EQUITY AND LIABILITIES

 

 

Equity share capital

3,767.00

3,767.00

Other equity

4,207.00

3,732.00

Non- controllable interests

-367.00

-407.00

Non-current liabilities

 

 

Contract liabilities

860

1004

Borrowings

5055

5324

Lease liabilities

14578

16089

Other financial liabilities

203

207

Provisions

1,127.00

1255

Current liabilities

 

 

Contract liabilities

7614

6467

Borrowings

5,096.00

6,259.00

Lease liabilities

5,109.00

6,641.00

Total outstanding dues of micro and small enterprises

241.00

253.00

Total outstanding dues of creditors other than micro and small enterprises

16,106.00

19,379.00

Other financial liabilities

3,784.00

3,769.00

Provisions

892.00

487.00

Other current liabilities

962.00

907.00

TOTAL EQUITY AND LIABILITIES

69,234.00

75,133.00

VLCC Health Care Limited Profit & Loss Statement (Rs in Lakhs)

PARTICULARS

 31 March 2021

 31 March 2020

Revenue from operations

53,292.00

76,957.00

Other income

3119

413

Total income

56,411.00

77,370.00

Cost of Material Consumed

9,762.00

13,187.00

Purchase of stock in trade

886

1,259.00

Changes in inventories of stock in trade

861

-954.00

Employee benefits expense

17,078.00

25,313.00

Other expenses

12,925.00

23,909.00

Total expenses

41,512.00

62,714.00

Earnings before interest, tax, depreciation and amortisation

14,899.00

14,656.00

Finance Income

113.00

133.00

Finance costs

4,585.00

5,443.00

depreciation and amortisation expenses

9,913.00

10,672.00

Profit/(Loss) before tax and exceptional items

514.00

-1,326.00

Exceptional items

-

327.00

Profit/(Loss) before tax and after exceptional items

514.00

-1,653.00

Current tax

214

230

Adjustments of tax relating to earlier years

22

-

Deferred tax credit

-346

-353

Profit/(Loss) for the year

624.00

-1,531.00

Re-measurements losses on defined benefit plans

-128

-23

Income tax credit

1

-

Exchanges differences on translation of foreign operations

17

309

Other comprehensive income/(loss) for the year

-110

286

Total comprehensive income/(loss) for the year

514.00

-1,245.00

Basic and diluted earnings per equity share (in INR)

-5.3

1.48

Profit/(Loss) for the year after tax

 

 

Attributable to:

 

 

Equity holders of parent

612

-1540

Non controllable interest

12

9

Other comprehensive income/(loss) for the year

 

 

Attributable to:

 

 

Equity holders of parent

-138

318

Non controllable interest

28

-32

Total comprehensive income/(loss) for the year

 

 

Attributable to:

 

 

Equity holders of parent

502

-1254

Non controllable interest

12

9

Earnings/ (loss) per share (INR)

 

 

Basic

1.63

-4.09

Diluted

1.62

-4.09

VLCC Health Care Limited Consolidated Cash Flow Statement (Rs in Lakhs)

Particulars

 31 March 2021

 31 March 2020

Cash flows from operating activities

 

 

Profit / (Loss) before tax and after exceptional items

514.00

-1,654.00

Adjustments for:

 

 

Depreciation and amortisation

9,913.00

10,672.00

Impairment of Goodwill

-

79.00

Allowances for doubtful trade receivables

1,183.00

1,139.00

Allowances for doubtful Advances

77.00

31.00

Provision for doubtful trade receivables written back

-26.00

-

Liabilities written back

-433.00

-3.00

Provision for inventories

477.00

874.00

provision for decommissioning liabilities

7.00

7.00

Loss on sale of property, plant and equipment

13.00

36.00

Finance costs

4,585.00

5,443.00

Lease concessions

-2,221.00

-

Gain on derecognition of lease liability

-208.00

-

Finance income

-113.00

-133.00

Unrealised foreign exchange (gain) / loss

-10.00

30.00

Operating profit before working capital changes

13,758.00

16,521.00

Decrease in trade payables and other liabilities

-2,472.00

-2,131.00

Increase/(decrease) in other liabilities

1,110.00

-1,526.00

Increase/(decrease) provisions

169.00

-227.00

(Increase)/decrease in trade receivables, loans and other financial assets

-2,337.00

853.00

(Increase)/decrease in inventories

1,101.00

-1,475.00

(Increase)/decrease in other assets

906.00

-125.00

Cash generated by operations

12,234.00

11,890.00

Direct taxes (paid)/Refund

-88.00

-172

Net cash generated by operating activities

12,147.00

11,718.00

Cash flows from investing activities

 

 

Proceeds from sale of property, plant and equipment

95.00

91.00

Purchase of PPE including capital advance

-1,830.00

-2,718.00

Interest received

36.00

127.00

(Investments)/ proceeds from bank deposits

449.00

-600.00

Net cash used in investing activities

-1,250.00

-3,100.00

Cash flows from financing activities

 

 

Proceeds from borrowings

1,770.00

4,084.00

Repayments of borrowings

-2,081.00

-5,633.00

Decrease in cash credits (net)

-963.00

-23.00

Payment of principal portion of lease liabilities

-2,469.00

-4,682.00

Interest Paid

-4,534.00

-5,377.00

Net cash generated from financing activities

-8,277.00

-11,631.00

Net increase/(decrease) in cash and cash equivalents during the year

2,620.00

-3,013.00

Cash and cash equivalents at the beginning of the year

1,214.00

4,227.00

Cash and cash equivalents at the end of the year

3,834.00

1,214.00

 Here is a summary of the Cash Flow Statement for the years 2021 and 2020:

Operating Activities:

Profit/Loss Before Tax and After Exceptional Items: The company reported a profit of 514.00 in 2021, contrasting with a loss of -1,654.00 in 2020, indicating a significant improvement in profitability.

Adjustments: Various adjustments were made, including depreciation, impairment charges, provisions for doubtful receivables and advances, finance costs, lease concessions, and unrealized foreign exchange gains/losses.

Operating Profit Before Working Capital Changes: Despite adjustments, the operating profit before working capital changes decreased slightly from 16,521.00 in 2020 to 13,758.00 in 2021.

Changes in Working Capital: The company experienced changes in trade payables, other liabilities, provisions, trade receivables, loans, inventories, and other assets, which affected cash flows from operations.

Cash Generated by Operations: The cash generated by operations remained relatively stable, amounting to 12,234.00 in 2021 and 11,890.00 in 2020.

Investing Activities:

Proceeds from Sale of Property, Plant, and Equipment: The company received proceeds from the sale of assets, amounting to 95.00 in 2021 and 91.00 in 2020.

Purchase of Property, Plant, and Equipment (PPE): Investments in PPE decreased from -2,718.00 in 2020 to -1,830.00 in 2021.

Interest Received and Investments: Interest received and investments in bank deposits fluctuated, impacting cash flows from investing activities.

Net Cash Used in Investing Activities: The net cash used in investing activities decreased from -3,100.00 in 2020 to -1,250.00 in 2021, primarily due to reduced investments in PPE.

Financing Activities:

Proceeds and Repayments of Borrowings: The company received proceeds from borrowings, but also made repayments, resulting in a decrease in borrowing activities from 4,084.00 in 2020 to 1,770.00 in 2021.

Decrease in Cash Credits: There was a decrease in cash credits, impacting financing activities negatively.

Payment of Lease Liabilities and Interest Paid: Payments of principal lease liabilities and interest expenses decreased from -5,377.00 in 2020 to -4,534.00 in 2021.

Net Cash Generated from Financing Activities: The net cash generated from financing activities decreased from -11,631.00 in 2020 to -8,277.00 in 2021.

Overall Cash Position:

Net Increase/Decrease in Cash: Despite a loss in cash and cash equivalents in 2020, the company experienced a significant increase in 2021, with a net increase of 2,620.00.

Cash and Cash Equivalents: The company ended 2021 with cash and cash equivalents of 3,834.00, compared to 1,214.00 in 2020, indicating improved liquidity and financial health.

Annual Report

VLCC Health Care Limited Annual Report 2021

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha

News Alert